Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Favourable effect of a 'second hit' after 13 weeks in early RA non-responders: the Amsterdam COBRA treat-to-target randomized trial.
Hartman L, Rasch LA, Turk SA, Ter Wee MM, Kerstens PJSM, van der Laken CJ, Nurmohamed MT, van Schaardenburg D, van Tuyl LHD, Voskuyl AE, Boers M, Lems WF. Hartman L, et al. Among authors: turk sa. Rheumatology (Oxford). 2023 Jun 1;62(6):2098-2105. doi: 10.1093/rheumatology/keac582. Rheumatology (Oxford). 2023. PMID: 36205538 Free PMC article. Clinical Trial.
Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial.
van Boheemen L, Turk S, Beers-Tas MV, Bos W, Marsman D, Griep EN, Starmans-Kool M, Popa CD, van Sijl A, Boers M, Nurmohamed MT, van Schaardenburg D. van Boheemen L, et al. RMD Open. 2021 Mar;7(1):e001591. doi: 10.1136/rmdopen-2021-001591. RMD Open. 2021. PMID: 33685928 Free PMC article. Clinical Trial.
14-3-3η Autoantibodies: Diagnostic Use in Early Rheumatoid Arthritis.
Maksymowych WP, Boire G, van Schaardenburg D, Wichuk S, Turk S, Boers M, Siminovitch KA, Bykerk V, Keystone E, Tak PP, van Kuijk AW, Landewé R, van der Heijde D, Murphy M, Marotta A. Maksymowych WP, et al. J Rheumatol. 2015 Sep;42(9):1587-94. doi: 10.3899/jrheum.141385. Epub 2015 Jul 15. J Rheumatol. 2015. PMID: 26178283
Comparing a tapering strategy to the standard dosing regimen of TNF inhibitors in rheumatoid arthritis patients with low disease activity.
Plasencia C, Wolbink G, Krieckaert CL, Kneepkens EL, Turk S, Jurado T, Martínez-Feito A, Navarro-Compán V, Bonilla G, Villalba A, Peiteado D, Nuño L, Martín-Mola E, Nurmohamed MT, van der Kleij D, Rispens T, Pascual-Salcedo D, Balsa A. Plasencia C, et al. Clin Exp Rheumatol. 2016 Jul-Aug;34(4):655-62. Epub 2016 May 19. Clin Exp Rheumatol. 2016. PMID: 27214767
Prediction of future rheumatoid arthritis.
Turk SA, van Beers-Tas MH, van Schaardenburg D. Turk SA, et al. Rheum Dis Clin North Am. 2014 Nov;40(4):753-70. doi: 10.1016/j.rdc.2014.07.007. Epub 2014 Sep 2. Rheum Dis Clin North Am. 2014. PMID: 25437290 Review.
15 results